A Systematic Review to Clarify the Prognostic Values of CD44 and CD44
CD44
CD44/CD24
cancer stem cell
cancer therapeutic resistance
prognosis
triple-negative breast cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
04
2021
accepted:
21
07
2021
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
27
8
2021
Statut:
epublish
Résumé
As a unique population of tumor bulk, cancer stem cells have been implicated in tumor relapse and chemoresistance in triple-negative breast cancer (TNBC). Therefore, understanding the phenotype of cancer stem cells can pave the way for introducing novel molecular targeted therapies for treating TNBC patients. Preclinical studies have identified CD44
Identifiants
pubmed: 34434894
doi: 10.3389/fonc.2021.689839
pmc: PMC8381605
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
689839Informations de copyright
Copyright © 2021 Abdoli Shadbad, Hosseinkhani, Asadzadeh, Derakhshani, Karim Ahangar, Hemmat, Lotfinejad, Brunetti, Silvestris and Baradaran.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Death Dis. 2020 Apr 23;11(4):266
pubmed: 32327629
Cancer Cell Int. 2020 Dec 7;20(1):583
pubmed: 33372595
Life Sci. 2020 Oct 1;258:118128
pubmed: 32710947
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oncologist. 2011;16 Suppl 1:1-11
pubmed: 21278435
Hum Pathol. 2015 Sep;46(9):1267-74
pubmed: 26170011
Eur J Pharmacol. 2021 Jul 15;903:174147
pubmed: 33961871
Int J Oncol. 2018 Jul;53(1):339-348
pubmed: 29750424
Cancer Res. 2011 Feb 1;71(3):895-905
pubmed: 21266361
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Mol Immunol. 2018 Jul;99:124-133
pubmed: 29777999
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Mol Biol Rep. 2020 Dec;47(12):9541-9551
pubmed: 33206362
Ann Intern Med. 2006 Mar 21;144(6):427-37
pubmed: 16549855
Breast Cancer Res Treat. 2017 Nov;166(2):421-433
pubmed: 28791489
Colloids Surf B Biointerfaces. 2016 Jul 1;143:532-546
pubmed: 27045981
Onco Targets Ther. 2011;4:71-8
pubmed: 21792314
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Biomed Pharmacother. 2021 Jun;138:111436
pubmed: 33667790
Front Cell Dev Biol. 2015 Aug 05;3:47
pubmed: 26301220
Front Immunol. 2021 Feb 22;12:623639
pubmed: 33692796
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Breast Cancer. 2020 Sep;27(5):989-998
pubmed: 32328816
Cancer Res. 2020 Feb 1;80(3):444-457
pubmed: 31722999
J Biol Chem. 2008 Jun 20;283(25):17635-51
pubmed: 18441325
Clin Dev Immunol. 2012;2012:708036
pubmed: 22693526
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11287-95
pubmed: 26617852
Diagnostics (Basel). 2020 Sep 17;10(9):
pubmed: 32957579
Nanomedicine. 2018 Apr 17;14(4):1441-1454
pubmed: 29678787
J Cell Physiol. 2021 Apr;236(4):2443-2458
pubmed: 32960465
Front Oncol. 2020 Jul 28;10:1083
pubmed: 32850312
Oncogene. 2019 May;38(21):4047-4060
pubmed: 30705400
Cancers (Basel). 2020 May 14;12(5):
pubmed: 32423137
Oncogene. 2004 Apr 29;23(20):3550-60
pubmed: 15116091
Int J Mol Sci. 2020 Nov 05;21(21):
pubmed: 33167514
Gene. 2018 Oct 30;675:128-135
pubmed: 29964098
Cancer Res. 2018 Jan 1;78(1):205-215
pubmed: 29263152
PLoS One. 2008 Aug 06;3(8):e2888
pubmed: 18682804
Cell Signal. 2015 Sep;27(9):1882-94
pubmed: 25979842
Oncotarget. 2015 May 10;6(13):11465-76
pubmed: 25888636
Pathol Res Pract. 2014 Jul;210(7):432-9
pubmed: 24726267
Oncol Lett. 2017 Nov;14(5):5890-5898
pubmed: 29113223
Exp Hematol Oncol. 2020 Dec 10;9(1):36
pubmed: 33303029
Leuk Lymphoma. 2011 Sep;52(9):1758-69
pubmed: 21649540
Nat Rev Cancer. 2008 Jul;8(7):545-54
pubmed: 18511937
J Clin Oncol. 2010 Sep 1;28(25):4006-12
pubmed: 20498387
Hum Pathol. 2016 Feb;48:48-55
pubmed: 26772398
Int J Clin Exp Pathol. 2020 May 01;13(5):1008-1016
pubmed: 32509072
Oncol Lett. 2016 Aug;12(2):1240-1256
pubmed: 27446423
Biomed Res Int. 2015;2015:158682
pubmed: 26504780
Oncogenesis. 2017 Apr 3;6(4):e310
pubmed: 28368389
Molecules. 2021 Apr 14;26(8):
pubmed: 33920054
Clin Cancer Res. 2016 Mar 15;22(6):1499-509
pubmed: 26515496
Oncotarget. 2017 Oct 20;8(59):99901-99912
pubmed: 29245948
Biomater Sci. 2020 May 21;8(10):2939-2954
pubmed: 32319481
J Biol Chem. 2005 May 27;280(21):20310-5
pubmed: 15784621
Onco Targets Ther. 2012;5:77-84
pubmed: 22649280
Med Oncol. 2015 Jan;32(1):275
pubmed: 25429827
Int J Biol Sci. 2016 Dec 7;12(12):1568-1577
pubmed: 27994520
Stem Cell Res. 2016 Mar;16(2):405-17
pubmed: 26926234
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
Int J Mol Med. 2020 Jun;45(6):1783-1792
pubmed: 32236608